These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15018249)

  • 81. Delivery of musculoskeletal therapy on line?
    Jull G; Moore A
    Man Ther; 2001 May; 6(2):65. PubMed ID: 11414774
    [No Abstract]   [Full Text] [Related]  

  • 82. Maximizing your place in healthcare's e-volution.
    Lanser EG
    Healthc Exec; 2000; 15(4):6-12. PubMed ID: 11182913
    [No Abstract]   [Full Text] [Related]  

  • 83. www.healthcarefuture.com.
    Beckham JD
    Health Forum J; 2000; 43(5):41-5. PubMed ID: 11066990
    [No Abstract]   [Full Text] [Related]  

  • 84. The need for leadership in a changing health care landscape.
    O'Neil E
    Pharmacotherapy; 2000 Aug; 20(8):891-4. PubMed ID: 10939548
    [No Abstract]   [Full Text] [Related]  

  • 85. Planning for the future.
    Crawford DS
    Am Pharm; 1987 Oct; NS27(10):10-1. PubMed ID: 3687720
    [No Abstract]   [Full Text] [Related]  

  • 86. Pharmacoeconomics of immunoglobulins and indications for their use.
    Guillevin L
    Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S53-5. PubMed ID: 23873314
    [No Abstract]   [Full Text] [Related]  

  • 87. The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia.
    Novakovic T; Martin AP; Parker M; Ferrario A; Vukovic S; Łanda K; Duba J; Dankó D; Kotsopoulos N; Godman B; Ristic J; Stefanovic D; Tesic D
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):519-521. PubMed ID: 28946800
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies: a health system perspective on thrombolytic therapy for acute myocardial infarction.
    Lewandowski CA; Kahler J
    Am Heart J; 1999 May; 137(5):S94-6. PubMed ID: 10220607
    [No Abstract]   [Full Text] [Related]  

  • 89. On pharmacogenomics in pharmacy benefit management.
    Russell Teagarden J; Stanek EJ
    Pharmacotherapy; 2012 Feb; 32(2):103-11. PubMed ID: 22392418
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evolving health care system: research issues and challenges.
    Mason HL
    Am J Pharm Educ; 1987; 51(4):396-9. PubMed ID: 10286993
    [No Abstract]   [Full Text] [Related]  

  • 91. Pharmacy in the twenty-first century: results of a strategic-planning conference.
    Am J Hosp Pharm; 1985 Jan; 42(1):71-80. PubMed ID: 3970032
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Terror's effect on technology adoption.
    Ochs J
    Manag Care; 2002 Jan; 11(1):52, 55. PubMed ID: 11828876
    [No Abstract]   [Full Text] [Related]  

  • 93. OUT ON A LIMB Two health care top 10 lists for the new year.
    Hosp Health Netw; 2015 Jan; 89(1):17-18. PubMed ID: 30280827
    [No Abstract]   [Full Text] [Related]  

  • 94. Changing the direction of clinical pharmacy outside the United States: time to step up.
    Gums JG
    Pharmacotherapy; 2013 Feb; 33(2):122-5. PubMed ID: 23386594
    [No Abstract]   [Full Text] [Related]  

  • 95. Policy forum: an interview with Don M. Newman.
    Newman DM
    Am Pharm; 1987 Oct; NS27(10):54-6. PubMed ID: 3318363
    [No Abstract]   [Full Text] [Related]  

  • 96. Economics—questions rather than answers.
    Thorp J
    BJOG; 2015 Aug; 122(9):1225. PubMed ID: 25573080
    [No Abstract]   [Full Text] [Related]  

  • 97. Croatian health in European transition.
    Lang S
    Croat Med J; 2001 Feb; 42(1):95-6. PubMed ID: 11172666
    [No Abstract]   [Full Text] [Related]  

  • 98. [Horizon 2025 for chronic care].
    Ambrosio L; García-Vivar C
    An Sist Sanit Navar; 2020 Apr; 43(1):5-7. PubMed ID: 32139912
    [No Abstract]   [Full Text] [Related]  

  • 99. The state of health economic research in South Africa.
    Gow J; Strauss M; Whiteside A
    Pharmacoeconomics; 2013 Mar; 31(3):251-3. PubMed ID: 23404128
    [No Abstract]   [Full Text] [Related]  

  • 100. The authors' reply to Gow et al.: "the state of health economic research in South Africa".
    Gavaza P; Rascati KL; Oladapo AO; Khoza S
    Pharmacoeconomics; 2013 Mar; 31(3):255-6. PubMed ID: 23430608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.